Screening and management of risk factors for cardiovascular disease in HIV-positive patients attending an Australian urban sexual health clinic
Sheena Kakar A , Douglas Drak B , Tahiya Amin C , Jason Cheung D , Catherine O’Connor A E F and David Gracey D F GA RPA Sexual Health Clinic, Community Health, Sydney Local Health District, Sydney, NSW 2050, Australia.
B Sydney Medical School, University of Sydney, Sydney, NSW 2006, Australia.
C Faculty of Medicine, UNSW, Sydney, NSW 2052, Australia.
D Renal Unit, Royal Prince Alfred Hospital, Sydney Local Health District, Sydney, NSW 2050, Australia.
E Kirby Institute, UNSW, NSW 2052, Australia.
F Central Clinical School, University of Sydney, Sydney, NSW 2006, Australia.
G Corresponding author. Email: david.gracey@sswahs.nsw.gov.au
Sexual Health 14(2) 198-200 https://doi.org/10.1071/SH16106
Submitted: 2 June 2016 Accepted: 27 September 2016 Published: 11 November 2016
Abstract
Background: Few data exist regarding cardiovascular risk among HIV-infected patients attending sexual health clinics (SHC) in Australia. Methods: The medical records of 188 patients attending an inner-city SHC between August 2013 and July 2014 were retrospectively reviewed for cardiovascular risk factors and associated screening and management practices. Results: Cardiovascular risk factors were common among attendees of the SHC, including smoking (38%), hypertension (14%) and dyslipidaemia (11%). Of the 188 patients, 23% reported using potentially cardiotoxic recreational drugs, 25% of dyslipidaemic patients were not on therapy and 10% of patients were hypertensive; none were prescribed treatment. A smoking cessation program was offered to all patients. Conclusion: A high prevalence of risk factors for cardiovascular disease was demonstrated. Modification of risk factors could be improved.
References
[1] Chan D, Gracey D, Bailey M, Richards D, Dalton B. Screening and management of cardiovascular disease in Australian adults with HIV infection. Sex Health 2013; 10 495–501.| Screening and management of cardiovascular disease in Australian adults with HIV infection.Crossref | GoogleScholarGoogle Scholar |
[2] Grierson JPM, Koelmeyer R. HIV futures seven: the health and wellbeing of HIV positive people in Australia. Melbourne: The Australian Research Centre in Sex, Health and Society, LaTrobe University; 2013.
[3] The Kirby Institute. Australian HIV observational database annual report 2015. Sydney: The Kirby Institute, University of New South Wales; 2015.
[4] National Vascular Disease Prevention Alliance (NVDPA). Guidelines for the management of absolute cardiovascular disease risk. NVDAP; 2012.
[5] National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand. Reducing risk in heart disease: an expert guide to clinical practice for secondary prevention of coronary heart disease. Melbourne: National Heart Foundation of Australia; 2012.
[6] Friis-Moller N, Sabin CA, Weber R, d’Arminio Monforte A, El-Sadr WM, Reiss P, et al Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 2003; 349 1993–2003.
| Combination antiretroviral therapy and the risk of myocardial infarction.Crossref | GoogleScholarGoogle Scholar |
[7] Rotger M, Glass TR, Junier T, Lundgren J, Neaton JD, Poloni ES, et al Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons. Nephrol Dial Transplant 2013; 57 112–21.
| 1:CAS:528:DC%2BC3sXptFelt70%3D&md5=b5818e6c5db591ae8e9ac49d56c21ec8CAS |
[8] Kaye S, McKetin R, Duflou J, Darke S. Methamphetamine and cardiovascular pathology: a review of the evidence. Addiction 2007; 102 1204–11.
| Methamphetamine and cardiovascular pathology: a review of the evidence.Crossref | GoogleScholarGoogle Scholar |
[9] Schwartz BG, Rezkalla S, Kloner RA. Cardiovascular effects of cocaine. Circulation 2010; 122 2558–69.
| Cardiovascular effects of cocaine.Crossref | GoogleScholarGoogle Scholar |
[10] Thylstrup B, Clausen T, Hesse M. Cardiovascular disease among people with drug use disorders. Int J Public Health 2015; 60 659–68.
| Cardiovascular disease among people with drug use disorders.Crossref | GoogleScholarGoogle Scholar |
[11] D’Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008; 117 743–53.
| General cardiovascular risk profile for use in primary care: the Framingham Heart Study.Crossref | GoogleScholarGoogle Scholar |
